Monophosphoryl Lipid A, or GLA-SE, is a synthetic toll-like receptor 4 agonist which enhances T-cell responses to influenza vaccine in older adults.
Biological Activity
Monophosphoryl lipid A (MPLA) is a natural agonist for the toll-like receptor-4 (TLR4). It is useful as an adjuvant in immunization. MPLA is a safe prophylactic agent and has immunotherapeutic applications. MPLA used in vaccination improves B cell and T cell-mediated immunity.
